SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001075970-08-000014
Filing Date
2008-06-05
Accepted
2008-06-05 15:36:38
Documents
1
Period of Report
2008-06-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3415
  Complete submission text file 0001075970-08-000014.txt   5315
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Issuer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1

Mailing Address C/O NUTRACEUTICAL CORPORATION 1400 KEARNS BOULEVARD, 2ND FLOOR PARK CITY X1 84060
Business Address 435-655-6000
Seelos Andrew W (Reporting) CIK: 0001396677 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23731 | Film No.: 08882952